Literature DB >> 24235069

Effect of thimerosal on the neurodevelopment of premature rats.

Yan-Ni Chen1, Jue Wang, Jie Zhang, Su-Jiao Li, Li He, Dong-Dong Shao, Hui-Ying Du.   

Abstract

BACKGROUND: This study was undertaken to determine the effect of thimerosal on the neurodevelopment of premature rats.
METHODS: Thimerosal was injected into premature SD rats at a dose of 32.8, 65.6, 98.4 or 131.2 μg/kg on postnatal day 1. Expression of dopamine D4 receptor (DRD4) and serotonin 2A receptor (5-HT2AR), apoptosis in the prefrontal cortex on post-injection day 49, and learning and memory function were studied and compared with those in a control group injected with saline.
RESULTS: Expression of DRD4 and 5-HT2AR and learning function decreased, and apoptosis increased significantly in the 131.2 μg/kg group (P<0.001). Memory function was significantly impaired by 65.6 (P<0.05), 98.4 and 131.2 μg/kg (P<0.001).
CONCLUSIONS: The negative adverse consequences on neurodevelopment observed in the present study are consistent with previous studies; this study raised serious concerns about adverse neurodevelopmental disorder such as autism in humans following the ongoing worldwide routine administration of thimerosalcontaining vaccines to infants.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24235069     DOI: 10.1007/s12519-013-0443-z

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  16 in total

1.  Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink.

Authors:  Heather A Young; David A Geier; Mark R Geier
Journal:  J Neurol Sci       Date:  2008-05-15       Impact factor: 3.181

2.  Intracellular calcium chelation and pharmacological SERCA inhibition of Ca2+ pump in the insular cortex differentially affect taste aversive memory formation and retrieval.

Authors:  María Isabel Miranda; Francisco J González-Cedillo; Mauricio Díaz-Muñoz
Journal:  Neurobiol Learn Mem       Date:  2011-04-18       Impact factor: 2.877

Review 3.  Alzheimer's disease and age-related memory decline (preclinical).

Authors:  Alvin V Terry; Patrick M Callahan; Brandon Hall; Scott J Webster
Journal:  Pharmacol Biochem Behav       Date:  2011-02-24       Impact factor: 3.533

4.  Influence of pediatric vaccines on amygdala growth and opioid ligand binding in rhesus macaque infants: A pilot study.

Authors:  Laura Hewitson; Brian J Lopresti; Carol Stott; N Scott Mason; Jaime Tomko
Journal:  Acta Neurobiol Exp (Wars)       Date:  2010       Impact factor: 1.579

5.  Identification and distribution of mercury species in rat tissues following administration of thimerosal or methylmercury.

Authors:  Jairo L Rodrigues; Juliana M Serpeloni; Bruno L Batista; Samuel S Souza; Fernando Barbosa
Journal:  Arch Toxicol       Date:  2010-04-13       Impact factor: 5.153

6.  Mitochondrial mediated thimerosal-induced apoptosis in a human neuroblastoma cell line (SK-N-SH).

Authors:  Michelle L Humphrey; Marsha P Cole; James C Pendergrass; Kinsley K Kiningham
Journal:  Neurotoxicology       Date:  2005-06       Impact factor: 4.294

7.  Dopamine D4 receptor transmission in the prefrontal cortex controls the salience of emotional memory via modulation of calcium calmodulin-dependent kinase II.

Authors:  Nicole M Lauzon; Tasha Ahmad; Steven R Laviolette
Journal:  Cereb Cortex       Date:  2011-11-24       Impact factor: 5.357

8.  Magnetic stimulation of the dorsolateral prefrontal cortex dissociates fragile visual short-term memory from visual working memory.

Authors:  Ilja G Sligte; Martijn E Wokke; Johannes P Tesselaar; H Steven Scholte; Victor A F Lamme
Journal:  Neuropsychologia       Date:  2010-12-17       Impact factor: 3.139

9.  Persistent behavioral impairments and alterations of brain dopamine system after early postnatal administration of thimerosal in rats.

Authors:  Mieszko Olczak; Michalina Duszczyk; Pawel Mierzejewski; Ksenia Meyza; Maria Dorota Majewska
Journal:  Behav Brain Res       Date:  2011-04-28       Impact factor: 3.332

10.  Neonatal exposure to Thimerosal from vaccines and child development in the first 3 years of life.

Authors:  Dorota Mrozek-Budzyn; Renata Majewska; Agnieszka Kieltyka; Malgorzata Augustyniak
Journal:  Neurotoxicol Teratol       Date:  2012-10-13       Impact factor: 3.763

View more
  9 in total

1.  Premature and neonate modeling of thimerosal exposure and neurodevelopment: additional comments.

Authors:  José G Dórea
Journal:  World J Pediatr       Date:  2014-05       Impact factor: 2.764

2.  The Novel Potential Therapeutic Utility of Montelukast in Alleviating Autistic Behavior Induced by Early Postnatal Administration of Thimerosal in Mice.

Authors:  Lobna A Abdelzaher; Ola A Hussein; I E M Ashry
Journal:  Cell Mol Neurobiol       Date:  2020-04-17       Impact factor: 5.046

3.  Effects of Treadmill Exercise on the Expression Level of BAX, BAD, BCL-2, BCL-XL, TFAM, and PGC-1α in the Hippocampus of Thimerosal-Treated Rats.

Authors:  Pouria Navazani; Salar Vaseghi; Mehrdad Hashemi; Mohammad-Reza Shafaati; Mohammad Nasehi
Journal:  Neurotox Res       Date:  2021-05-03       Impact factor: 3.911

Review 4.  Exposure to mercury and aluminum in early life: developmental vulnerability as a modifying factor in neurologic and immunologic effects.

Authors:  José G Dórea
Journal:  Int J Environ Res Public Health       Date:  2015-01-23       Impact factor: 3.390

Review 5.  Abnormalities in the zinc-metalloprotease-BDNF axis may contribute to megalencephaly and cortical hyperconnectivity in young autism spectrum disorder patients.

Authors:  Jae-Young Koh; Joon Seo Lim; Hyae-Ran Byun; Min-Heui Yoo
Journal:  Mol Brain       Date:  2014-09-03       Impact factor: 4.041

6.  A case-control study evaluating the relationship between thimerosal-containing haemophilus influenzae type b vaccine administration and the risk for a pervasive developmental disorder diagnosis in the United States.

Authors:  David A Geier; Janet K Kern; Paul G King; Lisa K Sykes; Mark R Geier
Journal:  Biol Trace Elem Res       Date:  2014-11-11       Impact factor: 3.738

7.  A longitudinal cohort study of the relationship between Thimerosal-containing hepatitis B vaccination and specific delays in development in the United States: Assessment of attributable risk and lifetime care costs.

Authors:  David A Geier; Janet K Kern; Brian S Hooker; Paul G King; Lisa K Sykes; Mark R Geier
Journal:  J Epidemiol Glob Health       Date:  2015-07-09

8.  Blockade of 5-Hydroxytryptamine 2A Receptor Attenuates Precipitation of Naloxone-Induced Withdrawal Symptoms in Opioid-Exposed Mice.

Authors:  Bing Li; Junyu Jiang; Li Zhou; Xinrong Tao; Qixian Sun; Jiaxin Liu; Yang Liu; Gang Pang
Journal:  Front Behav Neurosci       Date:  2022-02-09       Impact factor: 3.558

9.  Thimerosal-containing hepatitis B vaccination and the risk for diagnosed specific delays in development in the United States: a case-control study in the vaccine safety datalink.

Authors:  David A Geier; Janet K Kern; Brian S Hooker; Paul G King; Lisa K Sykes; Mark R Geier
Journal:  N Am J Med Sci       Date:  2014-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.